Ausgabe 12/2003
Inhalt (6 Artikel)
Original Article
Successful adoptive immunotherapy with vaccine-sensitized T cells, despite no effect with vaccination alone in a weakly immunogenic tumor model
Maryam Parviz, Cynthia S. Chin, Laura J. Graham, Catriona Miller, Catherine Lee, Kimberly George, Harry D. Bear
Original Article
Anti-Her-2/neu-IL-2 or heregulin-IL-2 fusions proteins redirect non-tumor specific CTL to the tumor site for tumor eradication
Joseph Lustgarten
Original Article
Identification of new MHC-restriction elements for presentation of the p210BCR-ABL fusion region to human cytotoxic T lymphocytes
Ji-Yao Sun, David Senitzer, Stephen J. Forman, Saswati Chatterjee, K. K. Wong Jr
Original Article
Natural CD8+ T-cell responses against MHC class I epitopes of the HER-2/neu oncoprotein in patients with epithelial tumors
Panagiota A. Sotiropoulou, Sonia A. Perez, Volfgang Voelter, Hartmut Echner, Ioannis Missitzis, Nick B. Tsavaris, Michael Papamichail, Constantin N. Baxevanis
Short Communication
Heparan sulphate epitope–expression is associated with the inflammatory response in metastatic malignant melanoma
Monique R. Bernsen, Toon F. C. M. Smetsers, Els van de Westerlo, Dirk J. Ruiter, Leif Håkansson, Bertil Gustafsson, Toin H. van Kuppevelt, Lennart Krysander, Björn Rettrup, Annika Håkansson